ALK-IN-29 (compound 4c) has a certain inhibitory effect on tyrosine protein kinases ALK , CDK2/CyclinE1 and FAK , among which the strongest inhibitory effect on ALK kinase is 40.63% at a concentration of 10 μM. ALK-IN-29 can be used for anti-cancer research.
Products are supplied to verified businesses, institutions, and qualified professionals for research and development use only. Not for use in humans, animals, diagnosis, or therapy.